Bioporto AS (OCSE:BIOPOR) COGS-to-Revenue : 0.36 (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS COGS-to-Revenue?

Bioporto AS's Cost of Goods Sold for the three months ended in Mar. 2025 was kr2.76 Mil. Its Revenue for the three months ended in Mar. 2025 was kr7.67 Mil.

Bioporto AS's COGS to Revenue for the three months ended in Mar. 2025 was 0.36.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bioporto AS's Gross Margin % for the three months ended in Mar. 2025 was 64.01%.

Bioporto AS COGS-to-Revenue Historical Data

The historical data trend for Bioporto AS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS COGS-to-Revenue Chart

Bioporto AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.43

0.38

0.34

0.35

0.32

Bioporto AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.24	0.24	0.31	0.53	0.36

Bioporto AS COGS-to-Revenue Calculation

Bioporto AS's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	11.713	/	36.243
	=	0.32

Bioporto AS's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	2.759	/	7.667
	=	0.36

Bioporto AS (OCSE:BIOPOR) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bioporto AS's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	2.759 / 7.667
	=	64.01 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Bioporto AS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioporto AS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioporto AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900

Website

https://www.bioporto.com

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines